Skip to main content
Clinical Trials/IRCT20230803059021N1
IRCT20230803059021N1
Not yet recruiting
Phase 2

Comparing the effectiveness of topiramate treatment with haloperidol in chronic tic disorder

Esfahan University of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
chronic tic disorder.
Sponsor
Esfahan University of Medical Sciences
Enrollment
32
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • parental informed consent
  • DSM\-V criteria for chronic tic disorder
  • age between 6 and 12

Exclusion Criteria

  • Presence of major medical disorders such as epilepsy, diabetes, heart and kidney diseases
  • mental retardation
  • Hypersensitivity to topiramate and haloperidol
  • The presence of concomitant psychiatric disorders that require drug intervention
  • History of long QT syndrome, cardiac arrhythmia, kidney stones and concurrent use of carbonic anhydrase inhibitor drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials